drugset / Trial / NCT03638869

Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REL-1017 (d-Methadone)

NCT03638869 ↗

Phase 1 Completed 24 enrolled Relmada Therapeutics, Inc.
RandomizedParallel-groupDouble-blindBasic science

Summary

This study evaluated the safety, tolerance, and pharmacokinetics (PK) of d-methadone in a limited dose range, in multiple administrations in humans.

Timeline

Start
2015-08-31
Primary completion
2015-11-16
Completion
2015-11-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Esmethadone Small molecule 25 mg Oral
Subject Esmethadone Small molecule 50 mg Oral
Subject Esmethadone Small molecule 75 mg Oral

Indications